These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Comparison of yttrium-90 radioembolization and transcatheter arterial chemoembolization for the treatment of unresectable hepatocellular carcinoma. Kooby DA; Egnatashvili V; Srinivasan S; Chamsuddin A; Delman KA; Kauh J; Staley CA; Kim HS J Vasc Interv Radiol; 2010 Feb; 21(2):224-30. PubMed ID: 20022765 [TBL] [Abstract][Full Text] [Related]
3. Survival benefit of radioembolization for inoperable hepatocellular carcinoma using yttrium-90 microspheres. Kwok PC; Leung KC; Cheung MT; Lam TW; Szeto LT; Chou SQ; Chia NH; Tong CM; Yuen PK; Cheung CH; Law CK J Gastroenterol Hepatol; 2014 Nov; 29(11):1897-904. PubMed ID: 24734957 [TBL] [Abstract][Full Text] [Related]
4. [Selective internal radiotherapy (SIRT) for hepatocellular carcinoma]. Antoch G; Mueller SP; Hamami M; Heusner TA; Ertle J; Hilgard P; Forsting M; Bockisch A Rofo; 2010 Aug; 182(8):660-70. PubMed ID: 20405369 [TBL] [Abstract][Full Text] [Related]
5. Yttrium-90 radioembolization for hepatocellular carcinoma: what we know and what we need to know. Kim YH; Kim DY Oncology; 2013; 84 Suppl 1():34-9. PubMed ID: 23428856 [TBL] [Abstract][Full Text] [Related]
6. Yttrium-90 radioembolization for the treatment of primary and metastatic liver tumors. Sato KT Semin Roentgenol; 2011 Apr; 46(2):159-65. PubMed ID: 21338841 [No Abstract] [Full Text] [Related]
18. Transarterial Chemoembolization and (90)Y Radioembolization for Hepatocellular Carcinoma: Review of Current Applications Beyond Intermediate-Stage Disease. Fidelman N; Kerlan RK AJR Am J Roentgenol; 2015 Oct; 205(4):742-52. PubMed ID: 26397322 [TBL] [Abstract][Full Text] [Related]
19. Yttrium-90 radioembolization using TheraSphere in the management of primary and secondary liver tumors. Riaz A; Lewandowski RJ; Kulik L; Salem R Q J Nucl Med Mol Imaging; 2009 Jun; 53(3):311-6. PubMed ID: 19521310 [TBL] [Abstract][Full Text] [Related]
20. Yttrium 90 radioembolization for the treatment of hepatocellular carcinoma: biological lessons, current challenges, and clinical perspectives. Salem R; Mazzaferro V; Sangro B Hepatology; 2013 Dec; 58(6):2188-97. PubMed ID: 23512791 [No Abstract] [Full Text] [Related] [Next] [New Search]